Literature DB >> 20740002

Neurodegeneration: An expansion in ALS genetics.

Clotilde Lagier-Tourenne, Don W Cleveland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20740002     DOI： 10.1038/4661052a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

2.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.

Authors:  G Imbert; F Saudou; G Yvert; D Devys; Y Trottier; J M Garnier; C Weber; J L Mandel; G Cancel; N Abbas; A Dürr; O Didierjean; G Stevanin; Y Agid; A Brice
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

3.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.

Authors:  S M Pulst; A Nechiporuk; T Nechiporuk; S Gispert; X N Chen; I Lopes-Cendes; S Pearlman; S Starkman; G Orozco-Diaz; A Lunkes; P DeJong; G A Rouleau; G Auburger; J R Korenberg; C Figueroa; S Sahba
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

4.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT.

Authors:  K Sanpei; H Takano; S Igarashi; T Sato; M Oyake; H Sasaki; A Wakisaka; K Tashiro; Y Ishida; T Ikeuchi; R Koide; M Saito; A Sato; T Tanaka; S Hanyu; Y Takiyama; M Nishizawa; N Shimizu; Y Nomura; M Segawa; K Iwabuchi; I Eguchi; H Tanaka; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

Review 5.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

7.  TDP-43 A315T mutation in familial motor neuron disease.

Authors:  Michael A Gitcho; Robert H Baloh; Sumi Chakraverty; Kevin Mayo; Joanne B Norton; Denise Levitch; Kimmo J Hatanpaa; Charles L White; Eileen H Bigio; Richard Caselli; Matt Baker; Muhammad T Al-Lozi; John C Morris; Alan Pestronk; Rosa Rademakers; Alison M Goate; Nigel J Cairns
Journal:  Ann Neurol       Date:  2008-02-20       Impact factor: 10.422

Review 8.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.

Authors:  Andrew C Elden; Hyung-Jun Kim; Michael P Hart; Alice S Chen-Plotkin; Brian S Johnson; Xiaodong Fang; Maria Armakola; Felix Geser; Robert Greene; Min Min Lu; Arun Padmanabhan; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Denise Juhr; Peter J Gruber; Udo Rüb; Georg Auburger; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Nancy M Bonini; Aaron D Gitler
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728
View more
  15 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  [Motor neuron diseases].

Authors:  S Petri; T Meyer
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 3.  MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.

Authors:  Paola Rinchetti; Mafalda Rizzuti; Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 4.  Modeling ALS and FTD with iPSC-derived neurons.

Authors:  Sebum Lee; Eric J Huang
Journal:  Brain Res       Date:  2015-10-14       Impact factor: 3.252

5.  Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.

Authors:  Teresa Lee; Yun R Li; Caroline Ingre; Markus Weber; Torsten Grehl; Ole Gredal; Mamede de Carvalho; Thomas Meyer; Ole-Björn Tysnes; Georg Auburger; Suzana Gispert; Nancy M Bonini; Peter M Andersen; Aaron D Gitler
Journal:  Hum Mol Genet       Date:  2011-02-03       Impact factor: 6.150

Review 6.  RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Authors:  Aaron D Gitler; James Shorter
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

7.  ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.

Authors:  Michael P Hart; Aaron D Gitler
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

8.  Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Authors:  Michael P Hart; Johannes Brettschneider; Virginia M Y Lee; John Q Trojanowski; Aaron D Gitler
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

9.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

10.  Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans.

Authors:  Melissa Nel; Thandeka Mavundla; Kayleigh Gultig; Gerrit Botha; Nicola Mulder; Michael Benatar; Joanne Wuu; Anne Cooley; Jason Myers; Evadnie Rampersaud; Gang Wu; Jeannine M Heckmann
Journal:  IBRO Neurosci Rep       Date:  2021-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.